TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 47 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,002 | +378.0% | 16,140 | 0.0% | 0.00% | – |
| Q2 2023 | $10,669 | -17.1% | 16,140 | 0.0% | 0.00% | – |
| Q1 2023 | $12,873 | -64.7% | 16,140 | 0.0% | 0.00% | – |
| Q4 2022 | $36,476 | +14.0% | 16,140 | 0.0% | 0.00% | – |
| Q3 2022 | $32,000 | -90.5% | 16,140 | -82.2% | 0.00% | – |
| Q2 2022 | $338,000 | -68.7% | 90,711 | -45.1% | 0.00% | – |
| Q1 2022 | $1,079,000 | -43.0% | 165,345 | +1.7% | 0.00% | -100.0% |
| Q4 2021 | $1,894,000 | -35.8% | 162,560 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $2,950,000 | +59.8% | 158,407 | +82.0% | 0.00% | 0.0% |
| Q2 2021 | $1,846,000 | +56.0% | 87,030 | +49.4% | 0.00% | – |
| Q1 2021 | $1,183,000 | -14.7% | 58,243 | +11.5% | 0.00% | -100.0% |
| Q4 2020 | $1,387,000 | – | 52,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |